Europe, the colorectal cancer market, is anticipated to reach US$ 5,573.2 Mn in 2027 from US$ 4,241.2 Mn in 2019. The market is projected to grow with a CAGR of 3.5% from 2020-2027.
The rise of the colorectal cancer market is driven by factors such as the increasing prevalence of colorectal cancer, and benefits offered by generic drugs that are boosting the market over the years. But, pricing pressure on drug manufacturers is likely to hinder the growth of the market in the future years.
Generic drugs are alternatives of branded drugs. The pharmacological effects of generic drugs are similar to their branded counterparts. Generic drugs are cost-effective as the manufacturers does not invest in the development and marketing a new drug. After the expiry of a drug patent, other manufacturers apply for FDA approval of a generic intended for its manufacturing and selling. Thus, the generic drugs are cheaper than their branded counterparts. The generic drug have exactly the same dosage, effects, side effects, route of administration, risks, safety, and strength as that of the original branded drugs. Generic drugs are important in oncology due to the fact that some of the anticancer drugs are only offered as generics. Patients are likely seen to abandon branded prescriptions which are majorly associated with their higher co-pays. Among developing countries such as India, where the paying capacity is relatively low, generic drugs for cancer treatment acts as a boon for both the manufacturers as well as patients due to its affordability and efficacy. For instance, in June 2016, Hetero launched a Biosimilar 'Bevacizumab' for the treatment of metastatic colorectal cancer under the brand name “Cizumab”. One of the most striking benefit of using generic drugs is the cost that is up to 85% less than that of the branded drugs.
In 2019, the Germany accounted for the largest market share in Europe colorectal cancer market, and it is also expected to grow at a faster pace over the forecast period. The market for colorectal cancer in the country is expected to grow due to the rising development in the field of cancer. Across the country, there are various biopharmaceutical and pharmaceutical companies. Various multinational companies are conducting market consolidation strategies to expand the oncology segment. Hence, considering the mentioned factors, the colorectal cancer market is expected to grow at a significant pace in the US during the forecast period.
Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE COLORECTAL CANCER – MARKET SEGMENTATION
By Modality
- Diagnosis Type
- Immunohistochemistry
- Stool Test
- Flexible Sigmoidoscopy
- Colonoscopy
- CEA Test
- Others
- Therapy Type
- Chemotherapy
- Alkylating Agent
- Antimetabolites
- Others
- Immunotherapy
- Panitumumab
- Cetuximab
- Bevacizumab
- Others
- Chemoprotectant
- Others
- Imaging Type
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Others
By End User
- Hospitals
- Diagnostic and Research Laboratories
By Geography
Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- Epigenomics AG
- Novigenix SA
- Clinical Genomics Technologies Pty Ltd.
- EDP Biotech Corporation
- Volitionrx Limited
- Abbott Laboratories
- Amgen Inc.
- F. Hoffmann-La Roche AG
- Bruker Corporation
- Quest Diagnostics Incorporated
- Natera, Inc.
- Guardant Health, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Modality, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Colorectal Cancer Market – By Modality
1.3.2 Europe Colorectal Cancer Market – By End User
1.3.3 Europe Colorectal Cancer Market – By Country
2. Europe Colorectal Cancer Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Colorectal Cancer Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Colorectal Cancer Market - Europe PEST Analysis
5. Europe Colorectal Cancer Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence Of Colorectal Cancer
5.1.2 Benefits Offered By Generic Drugs
5.2 Key Restraints
5.2.1 Pricing Pressure On Drug Manufacturers
5.3 Key Market Opportunities
5.3.1 Rising Healthcare Expenditure in Europe
5.4 Future Trend
5.4.1 Inclination Towards Personalized Medicine
5.5 Impact Analysis
6. Colorectal Cancer Market – Europe Analysis
6.1 Europe Colorectal Cancer Market Revenue Forecasts and Analysis
6.2 Positioning Of Key Players
7. Europe Colorectal Cancer Market Analysis And Forecasts To 2027 – Modality
7.1 Overview
7.2 Europe Colorectal Cancer Market, By Modality 2019 & 2027 (%)
7.2.1 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
7.2.1.1 Europe Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.2.1.2 Europe Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.2.1.2.1 Europe Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.2.1.2.2 Europe Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.2.1.3 Europe Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.3 Diagnosis Type Market
7.3.1 Overview
7.3.2 Diagnosis Type Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 Immunohistochemistry Market
7.3.3.1 Overview
7.3.3.2 Immunohistochemistry Market Revenue and Forecast to 2027 (US$ Mn)
7.3.4 Stool Test Market
7.3.4.1 Overview
7.3.4.2 Stool Test Market Revenue and Forecast to 2027 (US$ Mn)
7.3.5 Flexible Sigmoidoscopy Market
7.3.5.1 Overview
7.3.5.2 Flexible Sigmoidoscopy Market Revenue and Forecast to 2027 (US$ Mn)
7.3.6 Colonoscopy Market
7.3.6.1 Overview
7.3.6.2 Colonoscopy Market Revenue and Forecast to 2027 (US$ Mn)
7.3.7 CEA Test Market
7.3.7.1 Overview
7.3.7.2 CEA Test Market Revenue and Forecast to 2027 (US$ Mn)
7.3.8 Other Test Market
7.3.8.1 Overview
7.3.8.2 Other Test Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Therapy Type Market
7.4.1 Overview
7.4.2 Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 Chemotherapy Market
7.4.3.1 Overview
7.4.3.2 Chemotherapy Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3.3 Alkylating Agent Market
7.4.3.3.1 Overview
7.4.3.3.2 Alkylating Agent Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3.4 Antimetabolites Market
7.4.3.4.1 Antimetabolites Market Revenue and Forecast to 2027 (US$ Mn)
7.4.3.5 Others Market
7.4.3.5.1 Others Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4 Immunotherapy Market
7.4.4.1 Overview
7.4.4.2 Immunotherapy Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4.3 Panitumumab Market
7.4.4.3.1 Overview
7.4.4.3.2 Panitumumab Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4.4 Cetuximab Market
7.4.4.4.1 Overview
7.4.4.4.2 Cetuximab Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4.5 Bevacizumab Market
7.4.4.5.1 Overview
7.4.4.5.2 Bevacizumab Market Revenue and Forecast to 2027 (US$ Mn)
7.4.4.6 Others Market
7.4.4.6.1 Overview
7.4.4.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
7.4.5 Chemoprotectant Market
7.4.5.1 Overview
7.4.5.2 Chemoprotectant Market Revenue and Forecast to 2027 (US$ Mn)
7.4.6 Others Market
7.4.6.1 Overview
7.4.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Imaging Type Market
7.5.1 Overview
7.5.2 Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
7.5.3 Computed Tomography (CT) Market
7.5.3.1 Overview
7.5.3.2 Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)
7.5.4 Magnetic Resonance Imaging (MRI) Market
7.5.4.1 Overview
7.5.4.2 Magnetic Resonance Imaging (MRI) Market Revenue and Forecast to 2027 (US$ Mn)
7.5.5 Others Market
7.5.5.1 Overview
7.5.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
8. Europe Colorectal Cancer Market Analysis– By End User
8.1 Overview
8.2 Europe Colorectal Cancer Market, By End User 2019 & 2027 (%)
8.2.1 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
8.3 Hospitals Market
8.3.1 Overview
8.3.2 Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Diagnostic and Research Laboratories Market
8.4.1 Overview
8.4.2 Europe Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
9. Colorectal Cancer Market Revenue And Forecasts To 2027 – Geographical Analysis
9.1 Europe Colorectal Cancer Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 Europe Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.3 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
9.1.3.1 Europe Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.3.2 Europe Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.3.2.1 Europe Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.3.2.2 Europe Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.3.3 Europe Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.4 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.1.5 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
9.1.6 Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
9.1.6.2.1 Germany Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.6.2.2 Germany Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.6.2.2.1 Germany Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.6.2.2.2 Germany Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.6.2.3 Germany Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.6.3 Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.1.7 UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 UK Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
9.1.7.2.1 UK Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.7.2.2 UK Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.7.2.2.1 UK Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.7.2.2.2 UK Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.7.2.3 UK Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 UK Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.1.8 France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 France Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
9.1.8.2.1 France Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.8.2.2 France Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.8.2.2.1 France Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.8.2.2.2 France Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.8.2.3 France Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.8.3 France Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.1.9 Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.2 Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
9.1.9.2.1 Spain Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.9.2.2 Spain Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.9.2.2.1 Spain Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.9.2.2.2 Spain Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.9.2.3 Spain Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.9.3 Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.1.10 Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.1 Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.2 Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
9.1.10.2.1 Italy Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.10.2.2 Italy Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.10.2.2.1 Italy Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.10.2.2.2 Italy Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.10.2.3 Italy Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
9.1.10.3 Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10. Europe Colorectal Cancer Market- Industry Landscape
10.1 Overview
10.2 Growth Strategies In The Colorectal Cancer Market, 2016-2019
10.3 Organic Developments
10.3.1 Overview
10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2016-2019
10.4 Inorganic Developments
10.4.1 Overview
10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2016-2019
11. Colorectal Cancer Market–Key Company Profiles
11.1 Epigenomics AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Novigenix SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Clinical Genomics Technologies Pty Ltd.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 EDP Biotech Corporation
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Volitionrx Limited
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Abbott Laboratories
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Amgen Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 Pipeline (Clinical Trials) Portfolio
11.7.6 SWOT Analysis
11.7.7 Key Developments
11.8 F. Hoffmann-La Roche AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 Pipeline (Clinical Trials) Portfolio
11.8.6 SWOT Analysis
11.8.7 Key Developments
11.9 Bruker Corporation
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Quest Diagnostics Incorporated
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Natera, Inc.
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial Overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 Guardant Health, Inc.
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Financial Overview
11.12.4 Product Portfolio
11.12.5 SWOT Analysis
11.12.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
Table 2. Europe Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 3. Europe Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 4. Europe Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 5. Europe Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 6. Europe Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 7. Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 8. Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
Table 9. Europe Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 10. Europe Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 11. Europe Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 12. Europe Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 13. Europe Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 14. Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 15. Germany Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
Table 16. Germany Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 17. Germany Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 18. Germany Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 19. Germany Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 20. Germany Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 21. Germany Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 22. UK Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
Table 23. UK Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 24. UK Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 25. UK Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 26. UK Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 27. UK Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 28. UK Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 29. France Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
Table 30. France Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 31. France Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 32. France Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 33. France Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 34. France Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 35. France Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 36. Spain Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
Table 37. Spain Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 38. Spain Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 39. Spain Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 40. Spain Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 41. Spain Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 42. Spain Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 43. Italy Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
Table 44. Italy Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 45. Italy Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 46. Italy Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 47. Italy Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 48. Italy Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 49. Italy Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
Table 50. Recent Organic Growth Strategies In The Colorectal Cancer Market
Table 51. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
Table 52. Glossary of Terms, Colorectal Cancer Market
LIST OF FIGURES
Figure 1. Colorectal Cancer Market Segmentation
Figure 2. Europe Colorectal Cancer Market Overview
Figure 3. Diagnosis Type Segment Held Largest Share Of Modality Segment In Colorectal Cancer Market
Figure 4. Germany Is Expected To Show Remarkable Growth During The Forecast Period
Figure 5. Europe Colorectal Cancer Market- Leading Country Markets (US$ Mn)
Figure 6. Europe colorectal Cancer Market, Industry Landscape
Figure 7. Colorectal Cancer Market - Europe PEST Analysis
Figure 8. Comparison of Brand – Name Drugs and Generic Drugs
Figure 9. Colorectal Cancer Market Impact Analysis of Drivers And Restraints
Figure 10. Europe Colorectal Cancer Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 11. Market Positioning Of Key Player In Europe Colorectal Cancer Market
Figure 12. Europe Colorectal Cancer Market, by Modality 2019 & 2027 (%)
Figure 13. Diagnosis Type Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Immunohistochemistry Market Revenue And Forecasts To 2027 (US$ MN)
Figure 15. Stool Test Market Revenue And Forecasts To 2027 (US$ MN)
Figure 16. Flexible Sigmoidoscopy Market Revenue And Forecasts To 2027 (US$ MN)
Figure 17. Colonoscopy Market Revenue And Forecasts To 2027 (US$ MN)
Figure 18. CEA Test Market Revenue And Forecasts To 2027 (US$ MN)
Figure 19. Other Test Market Revenue And Forecasts To 2027 (US$ MN)
Figure 20. Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Chemotherapy Market Revenue And Forecasts To 2027 (US$ MN)
Figure 22. Alkylating Agent Market Revenue And Forecasts To 2027 (US$ MN)
Figure 23. Antimetabolites Market Revenue And Forecasts To 2027 (US$ MN)
Figure 24. Others Market Revenue And Forecasts To 2027 (US$ MN)
Figure 25. Immunotherapy Market Revenue And Forecasts To 2027 (US$ MN)
Figure 26. Panitumumab Market Revenue And Forecasts To 2027 (US$ MN)
Figure 27. Cetuximab Market Revenue And Forecasts To 2027 (US$ MN)
Figure 28. Bevacizumab Market Revenue And Forecasts To 2027 (US$ MN)
Figure 29. Others Market Revenue And Forecasts To 2027 (US$ MN)
Figure 30. Chemoprotectant Market Revenue And Forecasts To 2027 (US$ MN)
Figure 31. Others Market Revenue And Forecasts To 2027 (US$ MN)
Figure 32. Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 33. Computed Tomography (CT) Market Revenue And Forecasts To 2027 (US$ MN)
Figure 34. Magnetic Resonance Imaging (MRI) Market Revenue And Forecasts To 2027 (US$ MN)
Figure 35. Others Market Revenue And Forecasts To 2027 (US$ MN)
Figure 36. Europe Colorectal Cancer Market, by End User 2019 & 2027 (%)
Figure 37. Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. Europe Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 39. Europe Colorectal Cancer Market Revenue Overview, By Country (2019) (US$ Mn)
Figure 40. Europe Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
Figure 42. Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 45. Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 46. Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 47. Growth Strategies In The Colorectal Cancer Market, 2016-2019
The List of Companies - Europe Colorectal Cancer Market
- Epigenomics AG
- Novigenix SA
- Clinical Genomics Technologies Pty Ltd.
- EDP Biotech Corporation
- Volitionrx Limited
- Abbott Laboratories
- Amgen Inc.
- F. Hoffmann-La Roche AG
- Bruker Corporation
- Quest Diagnostics Incorporated
- Natera, Inc.
- Guardant Health, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Colorectal Cancer Market
Feb 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Feb 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Feb 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)